- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Sulfanilamide is an antibiotic drug used to treat a variety of bacterial infections. It is a sulfonamide, a type of synthetic antibiotic derived from para-aminobenzoic acid. It works by inhibiting the growth of bacteria, preventing them from reproducing and spreading. Sulfanilamide is used to treat a wide range of bacterial infections, including urinary tract infections, skin infections, and respiratory infections. It is also used to prevent infections in people who are at risk of developing them, such as those with weakened immune systems.
Sulfanilamide is available in a variety of forms, including tablets, capsules, and liquid suspensions. It is also available in combination with other antibiotics, such as trimethoprim and sulfamethoxazole. The drug is widely available over the counter and is also available by prescription.
The sulfanilamide market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more